FDA Clearance Tracker · P160022-S046
X Series®; Propaq MD®; AED 3 BLS; Zenix Professional Defibrillators
Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2025
Approved
Time to decision
168 days
Received Jul 3, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160022-S046
- Device name
- X Series®; Propaq MD®; AED 3 BLS; Zenix Professional Defibrillators
- Applicant
- ZOLL Medical Corporation
- Applicant location
- Chelsmford, MA
- Received
- Jul 3, 2025
- Decided
- Dec 18, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P160022
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.5310
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for updates to the labeling to add post-approval study results.
Source documents
Other decisions for ZOLL Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- 731 Series Ventilator510(k)
K233486 · Decided Dec 13, 2024 · 413 days after receipt
Device type: Ventilator, Continuous, Facility Use (CBK) · Anesthesiology & Respiratory
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.